NEWS: 公告在東京證券交易所JASDAQ標準市場新上市

表紙
市場調查報告書

人工電子耳的市場:2021年∼至2026年的預測

Cochlear Implant Market - Forecasts from 2021 to 2026

出版商 Knowledge Sourcing Intelligence 商品編碼 1023211
出版日期 內容資訊 英文 112 Pages
商品交期: 最快1-2個工作天內
價格
人工電子耳的市場:2021年∼至2026年的預測 Cochlear Implant Market - Forecasts from 2021 to 2026
出版日期: 2021年07月06日內容資訊: 英文 112 Pages
簡介

全球人工電子耳的市場規模,2019年價值20億7,100萬美元,預計以9.82%的年複合成長率 長,2026年達到39億9,000萬美元的市場規模。

人們的意識高漲,人工電子耳的進步,由於市場參與者的地理範圍擴大造成人工電子耳的普及率上升,政府的積極配合措施等,成為在預測期間內促進全球人工電子耳市場成長的主要原因。還有先進性的人工電子耳在兒童們之間普及事,及各國政府的輔助政策,預計更加促進市場成長。

然而,顏面神經的損傷、腦膜炎、暈眩和頭暈的發作等植入手術伴隨的風險可能妨礙市場成長。還有最近發生的新型冠狀病毒,給予全球人工電子耳市場負面影響。可是,由於全球大部分的地區法規正逐漸緩和,市場恢復,預計2022年以後以通常的步調發展。

本報告提供全球人工電子耳市場調查,市場概要,市場成長要素及阻礙因素分析,市場機會,各類型,各終端用戶,各地區的市場規模的變化與預測,競爭情形,主要企業簡介等資訊。

目錄

第1章 簡介

  • 市場定義
  • 市場區隔

第2章 調查手法

  • 調查資料
  • 假設

第3章 摘要整理

  • 調查的重點

第4章 市場動態

  • 市場推動因素
  • 市場阻礙因素
  • 波特的五力分析
    • 終端用戶談判力
    • 買方議價能力
    • 新加入業者的威脅
    • 替代品的威脅
    • 產業的競爭企業間的敵對關係
  • 產業的價值鏈分析

第5章 各類型的人工電子耳市場分析

  • 簡介
  • 單側植入
  • 兩側植入

第6章 各終端用戶的人工電子耳市場分析

  • 簡介
  • 大人
  • 小兒科

第7章 各地區的人工電子耳市場分析

  • 簡介
  • 北美
    • 美國
    • 加拿大
    • 墨西哥
  • 南美
    • 巴西
    • 阿根廷
    • 其他
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 其他
  • 中東和非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 其他
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • 韓國
    • 台灣
    • 泰國
    • 印尼
    • 其他

第8章 競爭環境與分析

  • 主要的參與者與策略分析
  • 新興參與者和市場收益性
  • 合併,收購,協定,及合作
  • 供應商競爭力矩陣

第9章 企業簡介

  • Cochlear Ltd.
  • MED-EL Medical Electronics
  • Sonova Group
  • Demant A/S
  • Nurotron Biotechnology Co. Ltd.
目錄
Product Code: KSI061614151

The global cochlear implant market is evaluated at US$2.071 billion for the year 2019 growing at a CAGR of 9.82% reaching a market size of US$3.990 billion by the year 2026. A cochlear implant is a surgically implanted electronic device designed to produce useful hearing sensations to a person with severe to profound nerve deafness by electrically stimulating nerves inside the inner ear. They are designed to help adults and children who get little or no benefit from hearing aids. Increasing awareness among people, advancements in cochlear implants, growing penetration of implants due to an expanded geographical reach of market players, and favorable government initiatives are the key drivers anticipated to boost the global cochlear implant market growth during the forecast period. Also, the rising adoption of advanced cochlear implants among children and supportive policies by the governments are anticipated to further propel market growth. However, risks associated with surgical implant procedures such as injury to the facial nerve, meningitis, attacks of dizziness or vertigo, and others can hamper the market growth.

The recent outbreak of the novel coronavirus had a negative impact on the global cochlear implant market. The pandemic shifted the major focus of the healthcare system towards COVID-19 and as part of the COVID-19 restrictions, a large number of surgeries had to be canceled in many parts of the world, which led to a decline in the global cochlear implant market in 2020. However, as the restrictions are being eased in most parts of the world, the market is anticipated to recover and continue at its normal pace from the year 2022 onwards.

Favorable government initiatives.

The governments in many countries around the world are increasingly providing assistance for cochlear implants, which is anticipated to propel the growth of the global cochlear implant market during the forecast period. Under the ADIP scheme of the Ministry of Social Justice and Empowerment, the government of India provides financial assistance for the cochlear implants of children and has recognized institutes of national stature for recommending children who are eligible for the scheme and for conducting the cochlear implants. The government bores the expense of the surgery with a ceiling limit of Rs 6 lakh per child. In April 2018, the government announced to have given implants to 1,200 children and stated its aim to increase the number of implants per year with the rising demand. The government of China has been providing subsidies for cochlear implants since 2015 for the people of Shanghai aged 18 to 60 who suffer from serious hearing loss. A subsidy with an upper limit of 60 thousand Yuan is provided at the designated hospitals to the local residents. The Ministry of Health of the government of New Zealand funds $8.7 million every year for cochlear implants in the country. The government in its manifesto has also committed to double the number of annual cochlear implants during the current parliamentary term. In February 2021, the MOH announced to invest an additional $6 million for adult cochlear implants. Many such initiatives have been taken by many other governments of various countries to make the lives of people requiring cochlear implants easy, and hence it is projected to boost the growth of the global cochlear implant market during the forecast period.

Rise in hearing loss cases.

One of the major factors anticipated to drive the growth of the global cochlear implant market is the growing number of people with hearing loss across the world. The WHO states that owing to the increasing prevalence of unsafe listening practices, more than 1 billion young adults are at risk of permanent and avoidable hearing loss as of March 2021. The WHO in its first world report on hearing stated that nearly 2.5 million people, or 25% of the population, will suffer from some sort of hearing loss by 2050. This rise in hearing loss cases is expected to increase the number of people requiring cochlear implants and hence is anticipated to boost the growth of the global cochlear implant market in the coming years. According to the World Population Ageing 2019 report by the Department of Economic & Social Affairs, UN, around 6% of the population was aged 65 or above in 1990 which increased to 9% in 2019, and it is projected to increase to 16% by 2050. The number of people aged 65 years or above is projected to increase from 703 million in 2019 to 1.5 billion by 2050. Around 1 in 11 people around the world was over the age of 65 in 2019 and it is projected to increase to 1 in 6 people by 2050, as per the report. With this rise in the geriatric population, the number of people having hearing problems is expected to increase, which is anticipated to propel the global cochlear implant market growth during the forecast period.

North America to hold a significant market share.

Geographically, the North American region is anticipated to hold a significant market share owing to the presence of a technologically advanced healthcare system and increasing awareness about cochlear implants and hearing issues. The Asia Pacific region is anticipated to witness substantial growth due to government support for cochlear implants.

Market Segmentation:

  • By Type

Unilateral Implants

Bilateral Implants

  • By End-User

Adult

Pediatric

  • By Geography

North America

  • USA
  • Canada
  • Mexico

South America

  • Brazil
  • Argentina
  • Others

Europe

  • Germany
  • France
  • UK
  • Others

Middle East and Africa

  • Saudi Arabia
  • UAE
  • Others

Asia Pacific

  • China
  • India
  • Japan
  • South Korea
  • Taiwan
  • Thailand
  • Indonesia
  • Others

Table of Contents

1. Introduction

  • 1.1. Market Definition
  • 1.2. Market Segmentation

2. Research Methodology

  • 2.1. Research Data
  • 2.2. Assumptions

3. Executive Summary

  • 3.1. Research Highlights

4. Market Dynamics

  • 4.1. Market Drivers
  • 4.2. Market Restraints
  • 4.3. Porters Five Forces Analysis
    • 4.3.1. Bargaining Power of End-Users
    • 4.3.2. Bargaining Power of Buyers
    • 4.3.3. Threat of New Entrants
    • 4.3.4. Threat of Substitutes
    • 4.3.5. Competitive Rivalry in the Industry
  • 4.4. Industry Value Chain Analysis

5. Cochlear Implant Market Analysis, by Type

  • 5.1. Introduction
  • 5.2. Unilateral Implants
  • 5.3. Bilateral Implants

6. Cochlear Implant Market Analysis, by End-User

  • 6.1. Introduction
  • 6.2. Adult
  • 6.3. Pediatric

7. Cochlear Implant Market Analysis, by Geography

  • 7.1. Introduction
  • 7.2. North America
    • 7.2.1. USA
    • 7.2.2. Canada
    • 7.2.3. Mexico
  • 7.3. South America
    • 7.3.1. Brazil
    • 7.3.2. Argentina
    • 7.3.3. Others
  • 7.4. Europe
    • 7.4.1. Germany
    • 7.4.2. France
    • 7.4.3. UK
    • 7.4.4. Others
  • 7.5. Middle East and Africa
    • 7.5.1. Saudi Arabia
    • 7.5.2. UAE
    • 7.5.3. Others
  • 7.6. Asia Pacific
    • 7.6.1. China
    • 7.6.2. India
    • 7.6.3. Japan
    • 7.6.4. South Korea
    • 7.6.5. Taiwan
    • 7.6.6. Thailand
    • 7.6.7. Indonesia
    • 7.6.8. Others

8. Competitive Environment and Analysis

  • 8.1. Major Players and Strategy Analysis
  • 8.2. Emerging Players and Market Lucrativeness
  • 8.3. Mergers, Acquisitions, Agreements, and Collaborations
  • 8.4. Vendor Competitiveness Matrix

9. Company Profiles

  • 9.1. Cochlear Ltd.
  • 9.2. MED-EL Medical Electronics
  • 9.3. Sonova Group
  • 9.4. Demant A/S
  • 9.5. Nurotron Biotechnology Co. Ltd.